Literature DB >> 18442642

Autogeneic feeders for the culture of undifferentiated human embryonic stem cells in feeder and feeder-free conditions.

Andre Choo1, Ang Sheu Ngo, Vanessa Ding, Steve Oh, Lim Sai Kiang.   

Abstract

Human embryonic stem cells (hESC) are pluripotent cells that proliferate indefinitely in culture while retaining their ability to differentiate to any cell type in the body. Conventionally, hESC are cultured either directly on feeders or on an extracellular matrix supplemented with conditioned medium (CM) from feeders. To minimize the risk of xenozootic infections, several sources of primary human feeders have been identified. However, this does not eliminate the risk of contaminating hESC with infectious agents from the donor human feeders. In this study, we evaluated the use of the CD105+ /CD24 hESC-derived mesenchymal stem cell (MSC) line, HuES9.E1, for its ability to support the growth of undifferentiated hESC in feeder and feeder-free cultures. This line was previously reported to be karyotypically stable and phenotypically displayed MSC-like surface antigens and gene transcription profiles. In addition, like adult MSC, HuES9.E1 can be differentiated to adipocytes, osteocytes, and chondrocytes in vitro. When tested for its ability to support hESC growth, it was found that hESC maintained the undifferentiated morphology for >12 continuous passages in coculture with HuES9.E1 and >8 passages in feeder-free cultures supplemented with CM from HuES9.E1. Furthermore, the hESC cultures continued to express the pluripotent markers, Oct-4, SSEA-4, Tra-1-60, Tra-1-81, and retained a normal karyotype. When injected into severe combined immunodeficient (SCID) mice, hESC differentiated to form teratomas comprising of tissues representative of the three embryonic germ layers. Potentially, the ability to derive and use autogeneic feeders may provide a safe and accessible source of feeders for the expansion of hESC required in clinical applications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18442642     DOI: 10.1016/S0091-679X(08)00002-2

Source DB:  PubMed          Journal:  Methods Cell Biol        ISSN: 0091-679X            Impact factor:   1.441


  9 in total

1.  Human embryonic stem cell-derived mesenchymal stromal cells.

Authors:  Peiman Hematti
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

2.  Endoplasmic reticulum stress signals in defined human embryonic stem cell lines and culture conditions.

Authors:  Miguel Angel Blanco-Gelaz; Beatriz Suarez-Alvarez; Gertrudis Ligero; Laura Sanchez; Jose Ramon Vidal-Castiñeira; Eliecer Coto; Harry Moore; Pablo Menendez; Carlos Lopez-Larrea
Journal:  Stem Cell Rev Rep       Date:  2010-09       Impact factor: 5.739

3.  A feeder-free culture using autogeneic conditioned medium for undifferentiated growth of human embryonic stem cells: comparative expression profiles of mRNAs, microRNAs and proteins among different feeders and conditioned media.

Authors:  Zong-Yun Tsai; Sher Singh; Sung-Liang Yu; Chi-Hsien Chou; Steven Shoei-Lung Li
Journal:  BMC Cell Biol       Date:  2010-10-12       Impact factor: 4.241

4.  Intercellular cytosolic transfer correlates with mesenchymal stromal cell rescue of umbilical cord blood cell viability during ex vivo expansion.

Authors:  Pat P Y Chu; Sudipto Bari; Xiubo Fan; Florence P H Gay; Justina M L Ang; Gigi N C Chiu; Sai K Lim; William Y K Hwang
Journal:  Cytotherapy       Date:  2012-07-10       Impact factor: 5.414

5.  Differentiation of embryonic stem cells into fibroblast-like cells in three-dimensional type I collagen gel cultures.

Authors:  Shinsaku Togo; Tadashi Sato; Hisatoshi Sugiura; Xingqi Wang; Hesham Basma; Amy Nelson; Xiangde Liu; Tom W Bargar; John G Sharp; Stephen I Rennard
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-11-25       Impact factor: 2.416

6.  Fibroblasts derived from human embryonic stem cells direct development and repair of 3D human skin equivalents.

Authors:  Yulia Shamis; Kyle J Hewitt; Mark W Carlson; Mariam Margvelashvilli; Shumin Dong; Catherine K Kuo; Laurence Daheron; Christophe Egles; Jonathan A Garlick
Journal:  Stem Cell Res Ther       Date:  2011-02-21       Impact factor: 6.832

7.  Human fetal liver stromal cells that overexpress bFGF support growth and maintenance of human embryonic stem cells.

Authors:  Jiafei Xi; Yunfang Wang; Peng Zhang; Lijuan He; Xue Nan; Wen Yue; Xuetao Pei
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

8.  Dosage and cell line dependent inhibitory effect of bFGF supplement in human pluripotent stem cell culture on inactivated human mesenchymal stem cells.

Authors:  Tara Quang; Maribel Marquez; Giselle Blanco; Yuanxiang Zhao
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

Review 9.  The therapeutic potential of mesenchymal stem cells for cardiovascular diseases.

Authors:  Yajun Guo; Yunsheng Yu; Yueqiu Chen; Shijun Hu; Zhenya Shen
Journal:  Cell Death Dis       Date:  2020-05-11       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.